fluconazole has been researched along with Myeloproliferative Disorders in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brissot, E | 1 |
| Cahu, X | 1 |
| Guillaume, T | 1 |
| Delaunay, J | 1 |
| Ayari, S | 1 |
| Peterlin, P | 1 |
| Le Bourgeois, A | 1 |
| Harousseau, JL | 1 |
| Milpied, N | 1 |
| Bene, MC | 1 |
| Moreau, P | 1 |
| Mohty, M | 1 |
| Chevallier, P | 1 |
1 other study available for fluconazole and Myeloproliferative Disorders
| Article | Year |
|---|---|
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
Topics: Acute Disease; Adult; Aged; Chemoprevention; Female; Fluconazole; Humans; Leukemia; Male; Middle Age | 2015 |